NextPlat (NXPL) Finished Goods (2017 - 2025)
NextPlat's (NXPL) quarterly Finished Goods came in at $3.8 million in Q4 2025, down 28.31% year-over-year from $5.3 million in Q4 2024, and down 37.23% quarter-over-quarter from $6.1 million in Q3 2025.
Analysis
NextPlat (NXPL) Finished Goods (2017 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Finished Goods for 9 consecutive years, with $3.8 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Finished Goods fell 28.31% year-over-year to $3.8 million in Q4 2025; TTM through Dec 2025 was $3.8 million, a 28.31% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, down 28.31% from the prior year.
- Finished Goods was $3.8 million for Q4 2025 at NextPlat, down from $6.1 million in the prior quarter.
- Over five years, Finished Goods peaked at $6.4 million in Q3 2024 and troughed at $982909.0 in Q3 2021.
- A 5-year average of $3.3 million and a median of $3.0 million in 2023 frame the typical range for Finished Goods.
- Across the five-year window, Finished Goods soared 341.6% in 2023 and decreased 28.31% in 2025, its largest moves.
- Over 5 years, Finished Goods stood at $1.0 million in 2021, then climbed by 26.21% to $1.3 million in 2022, then soared by 303.65% to $5.2 million in 2023, then grew by 2.41% to $5.3 million in 2024, then declined by 28.31% to $3.8 million in 2025.
- The last three Finished Goods figures came in at $3.8 million (Q4 2025), $6.1 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 6.08 Mn |
| Jun 30, 2025 | 5.67 Mn |
| Mar 31, 2025 | 4.93 Mn |
| Dec 31, 2024 | 5.32 Mn |
| Sep 30, 2024 | 6.45 Mn |
| Jun 30, 2024 | 4.75 Mn |
| Mar 31, 2024 | 5.67 Mn |
| Dec 31, 2023 | 5.20 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.14 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 982,909.00 |
| Jun 30, 2021 | 1.15 Mn |
| Mar 31, 2021 | 1.02 Mn |